JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB24186

Anti-CARD8 抗体

Anti-CARD8 antibody

4

(4 Reviews)

|

(16 Publications)

Anti-CARD8 antibody (ab24186) is a rabbit polyclonal antibody detecting CARD8 in Western Blot, ICC/IF. Suitable for Human.

- Over 10 publications
- Trusted since 2005

別名を表示する

DACAR, KIAA0955, NDPP1, CARD8, Caspase recruitment domain-containing protein 8, CARD-inhibitor of NF-kappa-B-activating ligand, Tumor up-regulated CARD-containing antagonist of CASP9, CARDINAL, TUCAN

4 Images
Western blot - Anti-CARD8 antibody (AB24186)
  • WB

Unknown

Western blot - Anti-CARD8 antibody (AB24186)

A peptide blocking study was also done (data not shown) and the only bands that disappeared were around 45kDa. The other bands are thought to be non-specific, but more testing to confirm or refute this has not been performed.

Lane 1:

Western blot - Anti-CARD8 antibody (ab24186) at 2 µg/mL

Lane 2:

Western blot - Anti-CARD8 antibody (ab24186) at 4 µg/mL

Predicted band size: 49 kDa

Observed band size: 45 kDa

false

Immunocytochemistry/ Immunofluorescence - Anti-CARD8 antibody (AB24186)
  • ICC/IF

Unknown

Immunocytochemistry/ Immunofluorescence - Anti-CARD8 antibody (AB24186)

ab24186 at 10μg/ml staining CARD8 in K562 cells by ICC/IF

Immunocytochemistry/ Immunofluorescence - Anti-CARD8 antibody (AB24186)
  • ICC/IF

AbReview29799****

Immunocytochemistry/ Immunofluorescence - Anti-CARD8 antibody (AB24186)

ab24186 staining CARD8 in Mouse RAW 264.7 cells by ICC/IF (Immunocytochemistry/immunofluorescence). Cells were fixed with paraformaldehyde, permeabilized with 0.1% Triton X-100 in 2% BSA and blocked with 2% serum for 1 hour at 22°C. Samples were incubated with primary antibody (1/200 in PBS + 2% BSA) for 18 hours at 4°C. An Alexa Fluor®488-conjugated Chicken anti-rabbit IgG polyclonal (1/750) was used as the secondary antibody.
WGA = Wheat Germ Agglutinin

This image is courtesy of an Abreview submitted by Dr Mahesh Shivananjappa

Immunocytochemistry/ Immunofluorescence - Anti-CARD8 antibody (AB24186)
  • ICC/IF

AbReview27994****

Immunocytochemistry/ Immunofluorescence - Anti-CARD8 antibody (AB24186)

ab24186 staining CARD8 in human monocytes by Immunocytochemistry/ Immunofluorescence.

Cells were fixed, permeabilized, blocked with 2% BSA for 30 minutes at 25°C and then incubated with ab24186 at a 1/200 dilution for 4 hours at 25°C. The secondary used was an Alexa-Fluor 488 conjugated chicken anti-rabbit IgG (H+L) used at a 1/1000 dilution.

Image courtesy of Dr Mahesh Shivananjappa by Abreview.

Key facts

宿主種

Rabbit

クローン性

Polyclonal

アイソタイプ

IgG

キャリアフリー

No

交差種

Human

アプリケーション

ICC/IF, WB

applications

免疫原

Synthetic Peptide within Human CARD8. The exact immunogen used to generate this antibody is proprietary information.

Q9Y2G2

特異性

ab24186 reacts with CARD8 (CARDINAL/TUCAN) protein.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "2 µg/mL", "WB-species-notes": "<p></p>", "ICCIF-species-checked": "testedAndGuaranteed", "ICCIF-species-dilution-info": "10 µg/mL", "ICCIF-species-notes": "<p></p>" } } }

製品の詳細

What is this antibody validated in?
Anti-CARD8 antibody (ab24186) is a rabbit polyclonal antibody and is validated for use in Western Blot (WB), Immunocytochemistry/immunofluorescence (ICC/IF) in Human samples.

What is the molecular weight of CARD8?
Anti-CARD8 (ab24186) specifically detects a band for CARD8 (UniProt: Q9Y2G2) at a molecular weight of 49kDa.

Trusted by the scientific community
Anti-CARD8 (ab24186) was first used in a scientific publication in 2005 and has been cited over 10 times in peer-reviewed journals.

出荷温度及び保存条件

製品の状態
Liquid
精製方法
Affinity purification Immunogen
バッファー組成
pH: 7.2 Preservative: 0.02% Sodium azide
出荷温度
Blue Ice
短期保存期間
1-2 weeks
短期保存温度
+4°C
長期保存温度
-20°C
保管に関する情報
Stable for 12 months at -20°C

補足情報

This supplementary information is collated from multiple sources and compiled automatically.

CARD8 also known as TUCAN or CARDINAL is a member of the CED-4 family of apoptosis proteins. This protein has a molecular mass of approximately 48 kDa. CARD8 expresses mostly in immune cells like monocytes and lymphocytes. Mechanically it possesses a caspase recruitment domain (CARD) which engages in protein-protein interactions. CARD8 interacts with components of the inflammasome playing a role in regulating apoptosis and inflammatory responses.
Biological function summary

CARD8 serves as a regulatory component in the innate immune system. It belongs to the NLR family and forms part of the inflammasome complex. Inflammasomes are essential for activating pro-inflammatory cytokines like IL-1Β. CARD8 modulates the activity of caspase-1 controlling cytokine maturation and secretion. By inhibiting the activation of these pro-inflammatory cytokines CARD8 affects the immune response during infections and inflammatory conditions.

Pathways

CARD8 is involved in both the inflammasome and apoptosis pathways. In the inflammasome pathway CARD8 interacts with proteins like NLRP3 and ASC to regulate caspase-1 activation. In the apoptosis pathway it connects with other proteins like caspase-9 influencing cell death processes. The integration into these pathways highlights CARD8's role in balancing immune response and cell survival.

CARD8 has links to various inflammatory diseases and cancers. CARD8 impacts ailments such as rheumatoid arthritis and certain types of cancer by its ability to influence apoptosis and inflammation. In rheumatoid arthritis altered CARD8 function can lead to excessive inflammation partly through its connection with NLRP3 and caspase-1. In cancer its dysregulation impacts tumor survival pathways potentially linking it with other proteins like caspase-9.

製品プロトコール

For this product, it's our understanding that no specific protocols are required. You can visit:

ターゲットの情報

Inflammasome sensor, which mediates inflammasome activation in response to various pathogen-associated signals, leading to subsequent pyroptosis of CD4(+) T-cells and macrophages (PubMed : 11408476, PubMed : 11821383, PubMed : 15030775, PubMed : 32051255, PubMed : 32840892, PubMed : 33542150, PubMed : 34019797, PubMed : 36357533). Inflammasomes are supramolecular complexes that assemble in the cytosol in response to pathogens and other damage-associated signals and play critical roles in innate immunity and inflammation (PubMed : 11408476, PubMed : 11821383, PubMed : 15030775, PubMed : 36357533). Acts as a recognition receptor (PRR) : recognizes specific pathogens and other damage-associated signals, such as HIV-1 protease activity or Val-boroPro inhibitor, and mediates CARD8 inflammasome activation (PubMed : 32840892, PubMed : 33542150, PubMed : 36357533). In response to pathogen-associated signals, the N-terminal part of CARD8 is degraded by the proteasome, releasing the cleaved C-terminal part of the protein (Caspase recruitment domain-containing protein 8, C-terminus), which polymerizes to initiate the formation of the inflammasome complex : the CARD8 inflammasome directly recruits pro-caspase-1 (proCASP1) independently of PYCARD/ASC and promotes caspase-1 (CASP1) activation, which subsequently cleaves and activates inflammatory cytokines IL1B and IL18 and gasdermin-D (GSDMD), leading to pyroptosis (PubMed : 32051255, PubMed : 32840892, PubMed : 33053349, PubMed : 33542150, PubMed : 36357533). Ability to sense HIV-1 protease activity leads to the clearance of latent HIV-1 in patient CD4(+) T-cells after viral reactivation; in contrast, HIV-1 can evade CARD8-sensing when its protease remains inactive in infected cells prior to viral budding (PubMed : 33542150). Also acts as a negative regulator of the NLRP3 inflammasome (PubMed : 24517500). May also act as an inhibitor of NF-kappa-B activation (PubMed : 11551959, PubMed : 12067710).. Caspase recruitment domain-containing protein 8. Constitutes the precursor of the CARD8 inflammasome, which mediates autoproteolytic processing within the FIIND domain to generate the N-terminal and C-terminal parts, which are associated non-covalently in absence of pathogens and other damage-associated signals.. Caspase recruitment domain-containing protein 8, N-terminus. Regulatory part that prevents formation of the CARD8 inflammasome : in absence of pathogens and other damage-associated signals, interacts with the C-terminal part of CARD8 (Caspase recruitment domain-containing protein 8, C-terminus), preventing activation of the CARD8 inflammasome (PubMed : 33542150). In response to pathogen-associated signals, this part is ubiquitinated by the N-end rule pathway and degraded by the proteasome, releasing the cleaved C-terminal part of the protein, which polymerizes and forms the CARD8 inflammasome (Probable) (PubMed : 32558991).. Caspase recruitment domain-containing protein 8, C-terminus. Constitutes the active part of the CARD8 inflammasome (PubMed : 32840892, PubMed : 34019797). In absence of pathogens and other damage-associated signals, interacts with the N-terminal part of CARD8 (Caspase recruitment domain-containing protein 8, N-terminus), preventing activation of the CARD8 inflammasome (PubMed : 33542150). In response to pathogen-associated signals, the N-terminal part of CARD8 is degraded by the proteasome, releasing this form, which polymerizes to form the CARD8 inflammasome complex : the CARD8 inflammasome complex then directly recruits pro-caspase-1 (proCASP1) and promotes caspase-1 (CASP1) activation, leading to gasdermin-D (GSDMD) cleavage and subsequent pyroptosis (PubMed : 32840892, PubMed : 33542150).
See full target information CARD8

文献 (16)

Recent publications for all applications. Explore the full list and refine your search

PloS one 19:e0314936 PubMed39705232

2024

Circular RNA circ-CARD8 regulates alveolar macrophage pyroptosis through the miR-580-3p/CARD8 pathway in acute lung injury.

Applications

Unspecified application

Species

Unspecified reactive species

Sida Chen,Ling Wen,Yumei Wu,Shan Xiao,Yuting Lai,Jintao Ou,Yan Shen

Cell 187:1223-1237.e16 PubMed38428396

2024

The CARD8 inflammasome dictates HIV/SIV pathogenesis and disease progression.

Applications

Unspecified application

Species

Unspecified reactive species

Qiankun Wang,Kolin M Clark,Ritudhwaj Tiwari,Nagarajan Raju,Gregory K Tharp,Jeffrey Rogers,R Alan Harris,Muthuswamy Raveendran,Steven E Bosinger,Tricia H Burdo,Guido Silvestri,Liang Shan

Journal of medicinal chemistry 66:2589-2607 PubMed36724486

2023

Optimized M24B Aminopeptidase Inhibitors for CARD8 Inflammasome Activation.

Applications

Unspecified application

Species

Unspecified reactive species

Qifeng Chen,Alvin Wang,Dominic J Covelli,Abir Bhattacharjee,Qinghui Wang,Elizabeth L Orth-He,Sahana D Rao,Hsin-Che Huang,Daniel P Ball,Jeffrey C Hsiao,Daniel A Bachovchin

Nature chemical biology 19:431-439 PubMed36357533

2022

Chemical inhibition of DPP9 sensitizes the CARD8 inflammasome in HIV-1-infected cells.

Applications

Unspecified application

Species

Unspecified reactive species

Kolin M Clark,Josh G Kim,Qiankun Wang,Hongbo Gao,Rachel M Presti,Liang Shan

The Journal of experimental medicine 219: PubMed36129453

2022

Viral proteases activate the CARD8 inflammasome in the human cardiovascular system.

Applications

Unspecified application

Species

Unspecified reactive species

Rhea Nadkarni,Wern Cui Chu,Cheryl Q E Lee,Yasir Mohamud,Lynn Yap,Gee Ann Toh,Sheryl Beh,Radiance Lim,Yiyun Michelle Fan,Yizhuo Lyanne Zhang,Kim Robinson,Karl Tryggvason,Honglin Luo,Franklin Zhong,Lena Ho

The Journal of biological chemistry 298:102032 PubMed35580636

2022

A ubiquitin-independent proteasome pathway controls activation of the CARD8 inflammasome.

Applications

Unspecified application

Species

Unspecified reactive species

Jeffrey C Hsiao,Atara R Neugroschl,Ashley J Chui,Cornelius Y Taabazuing,Andrew R Griswold,Qinghui Wang,Hsin-Che Huang,Elizabeth L Orth-He,Daniel P Ball,Giorgos Hiotis,Daniel A Bachovchin

Nature chemical biology 18:565-574 PubMed35165443

2022

M24B aminopeptidase inhibitors selectively activate the CARD8 inflammasome.

Applications

Unspecified application

Species

Unspecified reactive species

Sahana D Rao,Qifeng Chen,Qinghui Wang,Elizabeth L Orth-He,Michelle Saoi,Andrew R Griswold,Abir Bhattacharjee,Daniel P Ball,Hsin-Che Huang,Ashley J Chui,Dominic J Covelli,Shaochen You,Justin R Cross,Daniel A Bachovchin

Immunity 54:1392-1404.e10 PubMed34019797

2021

Dipeptidyl peptidase 9 sets a threshold for CARD8 inflammasome formation by sequestering its active C-terminal fragment.

Applications

Unspecified application

Species

Unspecified reactive species

Humayun Sharif,L Robert Hollingsworth,Andrew R Griswold,Jeffrey C Hsiao,Qinghui Wang,Daniel A Bachovchin,Hao Wu

Cell reports 33:108264 PubMed33053349

2020

Activation of the CARD8 Inflammasome Requires a Disordered Region.

Applications

Unspecified application

Species

Unspecified reactive species

Ashley J Chui,Andrew R Griswold,Cornelius Y Taabazuing,Elizabeth L Orth,Kuo Gai,Sahana D Rao,Daniel P Ball,Jeffrey C Hsiao,Daniel A Bachovchin

The EMBO journal 39:e105071 PubMed32840892

2020

CARD8 inflammasome activation triggers pyroptosis in human T cells.

Applications

Unspecified application

Species

Unspecified reactive species

Andreas Linder,Stefan Bauernfried,Yiming Cheng,Manuel Albanese,Christophe Jung,Oliver T Keppler,Veit Hornung
View all publications

Abcam product promise

当社は、高品質な試薬を通じてお客様の研究を力強くサポートすることをお約束いたします。ご使用いただく各段階で、常にお客様をサポートできる体制を整えております。万が一、製品が期待通りに機能しない場合は、「Abcam Product Promise」による当社保証制度に基づき、安心してご利用いただけます。
保証に関する詳細については利用規約をご確認ください。

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com